Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

What's Going On With LianBio (LIAN) Stock?

Author: Henry Khederian | March 15, 2024 03:44pm

LianBio – ADR (NASDAQ:LIAN) shares are trading higher by some 84% to $0.35 Friday afternoon on continued volatility. The company in late February announced its intent to delist its American Depositary Shares (ADSs) from the Nasdaq Global Market. This decision, made following a strategic review by the Board of Directors, involves winding down operations and deregistering its ordinary shares and ADSs.

The company aims to reduce costs associated with regulatory compliance and management time, while returning value to shareholders through asset sales, out-licensing efforts, and dividends. Trading of ADSs post-delisting is expected to shift to privately negotiated sales and potentially an over-the-counter market.

See Also: Cannabis Stocks Jump On News That DEA May Soon Undertake Marijuana Reform

LianBio shares have also seen volatility in recent weeks after the company completed its strategic review and determined to initiate the wind down of its operations, including the sale of remaining pipeline assets, delisting of ADS and workforce reductions. Also, the company declared a $4.80 special dividend.

See Also: AMD’s Success in Cloud Expansion – This Analyst Sees Potential for Market Leadership

Posted In: LIAN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist